Short answer
PULSE BIOSCIENCES, INC. (PLSE) filed an 8-K current report with the SEC on October 14, 2026 reporting Item 8.01 (Other Events). Commercial and clinical partnership with Clayman Thyroid Center and affiliates in Tampa, Florida.
PULSE BIOSCIENCES, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Commercial and clinical partnership with Clayman Thyroid Center and affiliates in Tampa, Florida
- Partnership will evaluate clinical utility of Pulse’s proprietary nPulse Vybrance Percutaneous Electrode System
- Potential validation and adoption pathway for the company’s technology in thyroid procedures
- No transaction value, revenue commitment, or commercialization timeline disclosed in the filing text
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PULSE BIOSCIENCES, INC. 8-K filings
Get the next PLSE 8-K as it lands
Follow PLSE for push alerts, or ask the research agent what this filing means.